Skip to content

Examination of the efficacy of the high gamma PGA natto on the suppression of postprandial glucose elevation by single-dose test.

Examination of the efficacy of the high gamma PGA natto on the suppression of postprandial glucose elevation by single-dose test. - The single-dose test of the high gamma PGA natto.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030182
Enrollment
20
Registered
2017-11-30
Start date
2017-12-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Low gamma PGA natto High gamma PGA natto

Sponsors

Course of clinical research and regional innovation donated by the Japan Agriculture Ibaraki Public Welfare Federation Fuculty of Medicine University of Tsukuba
Lead Sponsor
1.Takanofoods Co., Ltd. 2.Industrial technology insutitute of Ibaraki prefecture 3.National agriculture and food research organization, food research institute
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.BMI not less than 18.5 kg/m2, under 25.0 kg/m2. 2.FPG less than 126 mg/dL and HbA1c less than 6.5% and 2-hour post-75 g oral glucose tolerance test plasma glucose levels less than 200 mg/dL. 3.Capable of giving informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects who are treated for diabetes. 2. Subjects who are taking medications for dislipidemia, hypertention, and anemia. 3. Subjects who are taking warfarin. 4. Subjects who are habitually taking medication and/or supplement (including "food for specified health use", and "foods with function claims") that affect glucose metabolism. 5.Subjects who are diagnosed for anemia or have treatment history for anemia. 6. Subjects who are enrollment in another interventional study 7. Subjects who were recognized unsuitable for this study by the Investigator.

Design outcomes

Primary

MeasureTime frame
Incremental area under the curve of plasma glucose (0-120 min)

Secondary

MeasureTime frame
1.Plasma glucose level(0-120 min) 2.Plasma insulin level(0-120 min) 3.Organoleptic evaluation(eating quality of test meal)

Countries

Japan

Contacts

Public ContactKoichi Hashimoto

University of Tsukuba, Faculty of Medicene Course of clinical research and regional innovation donated by the Japan Agriculture Ibaraki Public

koichi.hashimoto@md.tsukuba.ac.jp029-853-3064

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026